Work

The δ-Opioid Receptor Agonist SNC80 [(+)-4-[α(R)-α-[(2 S,5 R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] Synergistically Enhances the Locomotor-Activating Effects of Some Psychomotor Stimulants, but Not Direct Dopamine Agonists, in Rats

Year: 2007

Type: article

Source: Journal of Pharmacology and Experimental Therapeutics

DOI: 10.1124/jpet.107.123844

Authors: Emily M. Jutkiewicz, Michelle G. Baladi, John E. Folk, Kenner C. Rice, James H. Woods

Institutions: University of Michigan, The University of Texas at San Antonio Health Science Center, National Institutes of Health

Language: English

Topic: Neurotransmitter Receptor Influence on Behavior

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute on Drug Abuse, National Institute of General Medical Sciences

Awards: G1090697414, G205218848, Postdoctoral Training in the Biology of Drug Abuse, G362632240, Interdepartmental Training in Pharmacological Sciences, Substance Abuse Interdisciplinary Training Program, G4974328972, G5902466936, Design, synthesis and characterization of dopamine receptor 3 ligands

OpenAlex ID: W1970089864

FWCI: 0.483

Cites: 35

Cited by: 19

Related to: 10